Technological Advancement in Organ-on-Chip Propels the Market Growth

Organ-on-a-chip market size was estimated at $130 million in 2024 and is projected to reach $4,035 million by 2035, growing at a CAGR of 36.7% from 2025 to 2035. Technological advancements in OoC technology are enabling the development of highly accurate human organ models. Market growth is being driven by increasing demand for drug screening and personalized medicine, particularly with the integration of patient-derived cells. Market players are actively contributing to innovation in the field by launching new OoC products in the market.

Browse the full report description of “Organ-on-Chip Market Size, Share & Trends Analysis Report by Organ Type (Liver, Kidney, Intestine, Lung, Heart, and Other Organ), by Model Type (Organ-Based Model, and Disease-Based Model), by Product (Instrument, Consumables and Reagents, Software, and Service), by Application (Drug Discovery, Toxicology Research, Physiological Model, Tissue Regeneration & Regenerative Medicine, Stem Cell Research, and Others), and by End-User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, and Cosmetics Industry), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/organ-on-chip-market

Key Players and Innovations

Several major players lead the tea market, including Emulate, Inc., InSphero AG, MIMETAS B.V., SynVivo, Inc., and TissUse GmbH. These companies are at the forefront of innovation, constantly developing new technologies to meet the industry's evolving needs. Some of the recent developments in the market include-

• In June 2025, World Precision Instruments, in collaboration with SynVivo Inc., introduced a next-generation multiplexed Trans Epithelial Electrical Resistance (TEER)-on-a-Chip platform, designed to provide real-time, high-throughput analysis of barrier integrity in advanced organ-on-a-chip systems.

• In March 2023, MIMETAS partnered with Astellas Pharma Inc. to leverage MIMETAS’ advanced tumor models in advancing the development of next-generation immuno-oncology therapies.

Market Coverage

• The market numbers available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Organ Type

o By Model Type 

o By Products

o By Application

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Emulate, Inc., InSphero AG, MIMETAS B.V., SynVivo, Inc., TissUse GmbH, and others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Organ-on-Chip Market Report Segment

By Organ Type

• Liver 
• Kidney
• Intestine
• Lung
• Heart
• Other Organ

By Model Type

• Organ-Based Model
• Disease-Based Model

By Products

• Instrument 
• Consumables and Reagents 
• Software
• Service

By Application

• Drug Discovery
• Toxicology Research
• Physiological Model
• Tissue Regeneration & Regenerative Medicine
• Stem Cell Research
• Others

By End-User 

• Pharmaceutical & Biotechnology Industry
• Academic & Research Institutes
• Cosmetics Industry

Global Organ-on-Chip Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/organ-on-chip-market